Development of a proprietary recombinant protein platform technologies designed to lead to new pharmaceutical products namely-- vaccines, antibiotics, antiviral, anti-inflammatory, anti-infectives, anti-fungals, antiprurities, cardiovascular agents, hormones, antineoplastics, anti-cancer, antipsychotics, anti-anginals, anti-thrombotics, anti-arrhythmia and anti-hypertensives

'agent':31 'angin':40 'anti':21,24,27,35,39,42,45,49 'anti-angin':38 'anti-arrhythmia':44 'anti-canc':34 'anti-fung':26 'anti-hypertens':48 'anti-infect':23 'anti-inflammatori':20 'anti-thrombot':41 'antibiot':18 'antineoplast':33 'antiprur':29 'antipsychot':37 'antivir':19 'arrhythmia':46 'cancer':36 'cardiovascular':30 'design':9 'develop':1 'fungal':28 'hormon':32 'hypertens':50 'infect':25 'inflammatori':22 'lead':11 'name':16 'new':13 'pharmaceut':14 'platform':7 'product':15 'proprietari':4 'protein':6 'recombin':5 'technolog':8 'thrombot':43 'vaccin':17

PROFICIA

Owners

Goods & Services